Pages that link to "Q35811415"
Jump to navigation
Jump to search
The following pages link to The Hippo-YAP pathway: new connections between regulation of organ size and cancer (Q35811415):
Displaying 50 items.
- Regulation of cell proliferation and apoptosis through fibrocystin-prosaposin interaction (Q24295259) (← links)
- PTPN14 is required for the density-dependent control of YAP1 (Q24297998) (← links)
- Components of the Hippo pathway cooperate with Nek2 kinase to regulate centrosome disjunction (Q24307199) (← links)
- The Hippo pathway regulates Wnt/beta-catenin signaling (Q24307606) (← links)
- Angiomotin-like proteins associate with and negatively regulate YAP1 (Q24321532) (← links)
- The Tumor Suppressor RASSF1A Prevents Dephosphorylation of the Mammalian STE20-like Kinases MST1 and MST2 (Q24322848) (← links)
- α-catenin is a tumor suppressor that controls cell accumulation by regulating the localization and activity of the transcriptional coactivator Yap1 (Q24613385) (← links)
- Structural and functional analysis of the YAP-binding domain of human TEAD2 (Q24623055) (← links)
- Organogenesis relies on SoxC transcription factors for the survival of neural and mesenchymal progenitors (Q24629179) (← links)
- Identification, basic characterization and evolutionary analysis of differentially spliced mRNA isoforms of human YAP1 gene (Q24634266) (← links)
- Regulation of TAZ in cancer (Q26740462) (← links)
- The MST/Hippo Pathway and Cell Death: A Non-Canonical Affair (Q26744308) (← links)
- Yap- and Cdc42-dependent nephrogenesis and morphogenesis during mouse kidney development (Q27323992) (← links)
- A critical role for NF2 and the Hippo pathway in branching morphogenesis (Q27334571) (← links)
- Structural basis of YAP recognition by TEAD4 in the Hippo pathway (Q27659390) (← links)
- Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy (Q28078129) (← links)
- Emerging evidence on the role of the Hippo/YAP pathway in liver physiology and cancer (Q28086905) (← links)
- Hippo/YAP pathway for targeted therapy (Q28088294) (← links)
- DLG5 in cell polarity maintenance and cancer development (Q28241647) (← links)
- Alteration of TEAD1 expression levels confers apoptotic resistance through the transcriptional up-regulation of Livin (Q28276187) (← links)
- The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version (Q28281214) (← links)
- Interaction with the Yes-associated protein (YAP) allows TEAD1 to positively regulate NAIP expression (Q28297744) (← links)
- Regulation of mouse embryonic stem cell self-renewal by a Yes–YAP–TEAD2 signaling pathway downstream of LIF (Q28504558) (← links)
- Ablation of Rassf2 induces bone defects and subsequent haematopoietic anomalies in mice (Q28509403) (← links)
- Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver (Q28587974) (← links)
- The related transcriptional enhancer factor-1 isoform, TEAD4(216), can repress vascular endothelial growth factor expression in mammalian cells (Q28728051) (← links)
- Cooperation between dE2F1 and Yki/Sd defines a distinct transcriptional program necessary to bypass cell cycle exit (Q28742574) (← links)
- E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components. (Q28972461) (← links)
- The nuts and bolts of AGC protein kinases (Q29617465) (← links)
- Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway (Q29871425) (← links)
- Mutant p53 Protein and the Hippo Transducers YAP and TAZ: A Critical Oncogenic Node in Human Cancers. (Q30354662) (← links)
- Junctional music that the nucleus hears: cell-cell contact signaling and the modulation of gene activity. (Q30384261) (← links)
- The Hippo signaling pathway in stem cell biology and cancer (Q30410176) (← links)
- Yap1 protein regulates vascular smooth muscle cell phenotypic switch by interaction with myocardin (Q30419759) (← links)
- Genetic control of programmed cell death during animal development (Q33589613) (← links)
- Liver-specific ablation of integrin-linked kinase in mice results in enhanced and prolonged cell proliferation and hepatomegaly after phenobarbital administration (Q33592989) (← links)
- YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway (Q33644875) (← links)
- The biomolecular era for thoracic surgeons: the example of the ESTS Biology Club (Q33658238) (← links)
- LATS2 is De-methylated and Overexpressed in Nasopharyngeal Carcinoma and Predicts Poor Prognosis (Q33713184) (← links)
- Deletion of yes-associated protein (YAP) specifically in cardiac and vascular smooth muscle cells reveals a crucial role for YAP in mouse cardiovascular development (Q33725751) (← links)
- Involvement of members of the cadherin superfamily in cancer (Q33899441) (← links)
- Loss of Bicc1 impairs tubulomorphogenesis of cultured IMCD cells by disrupting E-cadherin-based cell-cell adhesion (Q33915177) (← links)
- Prognostic impact of TAZ and β-catenin expression in adenocarcinoma of the esophagogastric junction (Q33926592) (← links)
- KRAS and YAP1 converge to regulate EMT and tumor survival (Q33946244) (← links)
- Taz-tead1 links cell-cell contact to zeb1 expression, proliferation, and dedifferentiation in retinal pigment epithelial cells (Q33994131) (← links)
- Loss of the Drosophila cell polarity regulator Scribbled promotes epithelial tissue overgrowth and cooperation with oncogenic Ras-Raf through impaired Hippo pathway signaling (Q34034164) (← links)
- Nf2/Merlin controls progenitor homeostasis and tumorigenesis in the liver (Q34069370) (← links)
- Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling (Q34074921) (← links)
- Downregulation of SAV1 plays a role in pathogenesis of high-grade clear cell renal cell carcinoma (Q34106752) (← links)
- Yes-associated protein is involved in proliferation and differentiation during postnatal liver development (Q34109681) (← links)